|
Lavin M, Aguila S, Schneppenheim S, Dalton N, Jones KL, O'Sullivan JM, O'Connell NM, Ryan K, White B, Byrne M, Rafferty M, Doyle MM, Nolan M, Preston RJS, Budde U, James P, Di Paola J, O'Donnell JS. Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels. Blood. 2017 Nov 23;130(21):2344-2353. doi: 10.1182/blood-2017-05-786699. Epub 2017 Sep 15. PubMed PMID: 28916584; PubMed Central PMCID: PMC5881608.
AÑO: 2017; IF: 25.476
|
28916584
|
Águila S, Izaguirre G, Martínez-Martínez I, Vicente V, Olson ST, Corral J. Disease-causing mutations in the serpin antithrombin reveal a key domain critical for inhibiting protease activities. J Biol Chem. 2017 Oct 6;292(40):16513-16520. doi: 10.1074/jbc.M117.787325. Epub 2017 Jul 25. PubMed PMID: 28743742; PubMed Central PMCID: PMC5633112.
AÑO: 2017; IF: 4.01
|
|
Bohdan N, Espín S, Águila S, Teruel-Montoya R, Vicente V, Corral J, Martínez-Martínez I. Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site. PLoS One. 2016 Jun 20;11(6):e0157834. doi: 10.1371/journal.pone.0157834. eCollection 2016. PubMed PMID: 27322195; PubMed Central PMCID: PMC4913942.
AÑO: 2016; IF: 2.806
|
|
O'Sullivan JM, Aguila S, McRae E, Ward SE, Rawley O, Fallon PG, Brophy TM, Preston RJ, Brady L, Sheils O, Chion A, O'Donnell JS. N-linked glycan truncation causes enhanced clearance of plasma-derived von Willebrand factor. J Thromb Haemost. 2016 Dec;14(12):2446-2457. doi: 10.1111/jth.13537. Epub 2016 Dec 9. PubMed PMID: 27732771.
AÑO: 2016; IF: 16.036
|
|
Luengo-Gil G, Calvo MI, Martín-Villar E, Águila S, Bohdan N, Antón AI, Espín S, Ayala de la Peña F, Vicente V, Corral J, Quintanilla M, Martínez-Martínez I. Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase. Sci Rep. 2016 Jun 8;6:27544. doi: 10.1038/srep27544. PubMed PMID: 27270881; PubMed Central PMCID: PMC4897635.
AÑO: 2016; IF: 4.259
|